123 related articles for article (PubMed ID: 24569555)
1. Do statins increase the risk of diabetes or is it guilt by association?
Mogadam M
Curr Opin Endocrinol Diabetes Obes; 2014 Apr; 21(2):140-5. PubMed ID: 24569555
[TBL] [Abstract][Full Text] [Related]
2. Is statin-induced diabetes clinically relevant? A comprehensive review of the literature.
Bell DS; DiNicolantonio JJ; O'Keefe JH
Diabetes Obes Metab; 2014 Aug; 16(8):689-94. PubMed ID: 24373206
[TBL] [Abstract][Full Text] [Related]
3. Statin therapy and the risk for diabetes among adult women: do the benefits outweigh the risk?
Ma Y; Culver A; Rossouw J; Olendzki B; Merriam P; Lian B; Ockene I
Ther Adv Cardiovasc Dis; 2013 Feb; 7(1):41-4. PubMed ID: 23238515
[TBL] [Abstract][Full Text] [Related]
4. Diabetogenic Action of Statins: Mechanisms.
Carmena R; Betteridge DJ
Curr Atheroscler Rep; 2019 Apr; 21(6):23. PubMed ID: 31037345
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10?
Chan DC; Pang J; Watts GF
Curr Atheroscler Rep; 2015 Jan; 17(1):472. PubMed ID: 25398645
[TBL] [Abstract][Full Text] [Related]
6. Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.
Leiter LA; Lundman P; da Silva PM; Drexel H; Jünger C; Gitt AK;
Diabet Med; 2011 Nov; 28(11):1343-51. PubMed ID: 21679231
[TBL] [Abstract][Full Text] [Related]
7. Statin therapy and related risk of new-onset type 2 diabetes mellitus.
Ruscica M; Macchi C; Morlotti B; Sirtori CR; Magni P
Eur J Intern Med; 2014 Jun; 25(5):401-6. PubMed ID: 24685426
[TBL] [Abstract][Full Text] [Related]
8. Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.
Izzo R; de Simone G; Trimarco V; Giudice R; De Marco M; Di Renzo G; De Luca N; Trimarco B
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1101-6. PubMed ID: 23419735
[TBL] [Abstract][Full Text] [Related]
9. Use of statins and the incidence of type 2 diabetes mellitus.
Bernardi A; Rocha VZ; Faria-Neto JR
Rev Assoc Med Bras (1992); 2015 Aug; 61(4):375-80. PubMed ID: 26466221
[TBL] [Abstract][Full Text] [Related]
10. Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study.
Chapman RH; Petrilla AA; Berman L; Benner JS; Tang SS
Am J Cardiovasc Drugs; 2009; 9(5):299-308. PubMed ID: 19791839
[TBL] [Abstract][Full Text] [Related]
11. Statins and diabetes risk: how real is it and what are the mechanisms?
Robinson JG
Curr Opin Lipidol; 2015 Jun; 26(3):228-35. PubMed ID: 25887679
[TBL] [Abstract][Full Text] [Related]
12. Statin-Associated Diabetes Mellitus: Review and Clinical Guide.
Backes JM; Kostoff MD; Gibson CA; Ruisinger JF
South Med J; 2016 Mar; 109(3):167-73. PubMed ID: 26954655
[TBL] [Abstract][Full Text] [Related]
13. Statins and New-Onset Diabetes Mellitus and Diabetic Complications: A Retrospective Cohort Study of US Healthy Adults.
Mansi I; Frei CR; Wang CP; Mortensen EM
J Gen Intern Med; 2015 Nov; 30(11):1599-610. PubMed ID: 25917657
[TBL] [Abstract][Full Text] [Related]
14. The diabetogenic action of statins - mechanisms and clinical implications.
Betteridge DJ; Carmena R
Nat Rev Endocrinol; 2016 Feb; 12(2):99-110. PubMed ID: 26668119
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias.
Suh HS; Hay JW; Johnson KA; Doctor JN
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):470-84. PubMed ID: 22461130
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins.
Ko DT; Wijeysundera HC; Jackevicius CA; Yousef A; Wang J; Tu JV
Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):315-22. PubMed ID: 23674307
[TBL] [Abstract][Full Text] [Related]
17. The controversies of statin therapy: weighing the evidence.
Jukema JW; Cannon CP; de Craen AJ; Westendorp RG; Trompet S
J Am Coll Cardiol; 2012 Sep; 60(10):875-81. PubMed ID: 22902202
[TBL] [Abstract][Full Text] [Related]
18. Predicting the impact of polypill use in a metabolic syndrome population: an effectiveness and cost-effectiveness analysis.
Zomer E; Owen A; Magliano DJ; Ademi Z; Reid CM; Liew D
Am J Cardiovasc Drugs; 2013 Apr; 13(2):121-8. PubMed ID: 23532687
[TBL] [Abstract][Full Text] [Related]
19. [Statin treatment causes an increased risk of type 2 diabetes].
Solis AB; Pilemann-Lyberg S; Gæde P
Ugeskr Laeger; 2014 Feb; 176(3):227-31. PubMed ID: 24629749
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome: diabetes and cardiovascular disease.
Gupta S; Gupta BM
Indian Heart J; 2006; 58(2):149-52. PubMed ID: 18989060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
